Shahrzad Salmasi

ORCID: 0000-0003-1330-3388
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Atrial Fibrillation Management and Outcomes
  • Medication Adherence and Compliance
  • Health Systems, Economic Evaluations, Quality of Life
  • Blood Pressure and Hypertension Studies
  • Pharmaceutical Practices and Patient Outcomes
  • Pharmaceutical industry and healthcare
  • Cardiac and Coronary Surgery Techniques
  • Pharmaceutical Economics and Policy
  • Pharmaceutical studies and practices
  • Venous Thromboembolism Diagnosis and Management
  • Cardiac, Anesthesia and Surgical Outcomes
  • Patient Safety and Medication Errors
  • Economic and Financial Impacts of Cancer
  • Antiplatelet Therapy and Cardiovascular Diseases
  • Rheumatoid Arthritis Research and Therapies
  • Infective Endocarditis Diagnosis and Management
  • Cardiac Arrhythmias and Treatments
  • Cardiac Valve Diseases and Treatments
  • Pharmacy and Medical Practices
  • Hemodynamic Monitoring and Therapy
  • Antibiotic Use and Resistance
  • Acute Ischemic Stroke Management
  • Trauma, Hemostasis, Coagulopathy, Resuscitation
  • Healthcare Quality and Management
  • Thermoregulation and physiological responses

Jewish General Hospital
2022-2024

McGill University
2022-2024

University of British Columbia
2016-2023

Centre for Health Evaluation and Outcome Sciences
2016-2021

Research Canada
2019-2020

University of Otago
2020

College of Pharmacists of British Columbia
2020

Monash University Malaysia
2015-2017

Tabriz University of Medical Sciences
2004-2007

Globally, cancer is one of the leading causes mortality. High treatment cost, partly owing to higher prices anti-cancer drugs, presents a significant burden on patients and healthcare systems. The aim present study was survey compare retail drugs between high, middle low income countries in South-East Asia, Western Pacific Eastern Mediterranean regions. Cross-sectional design used for study. Pricing data from ten counties including two seven regions were this Purchasing power parity...

10.1186/s12885-017-3888-y article EN cc-by BMC Cancer 2017-12-01

Objective To evaluate the association between adherence to antimalarials and type 2 diabetes mellitus (DM) in patients with systemic lupus erythematosus (SLE). Methods Using administrative health databases British Columbia, Canada, we conducted a retrospective, longitudinal cohort study of incident SLE antimalarial use. We established drug courses by defining new course when 90‐day gap is exceeded refills calculated proportion days covered (PDC) for each course. categorized medication taking...

10.1002/acr.24147 article EN Arthritis Care & Research 2020-01-21

Background: Stroke prevention therapy decisions for patients with atrial fibrillation (AF) are complex and require trade-offs, but few validated patient decision aids (PDAs) available to facilitate shared making. Objective: To evaluate the effects of a novel PDA on decision-making parameters AF choosing stroke therapy. Methods: We developed an evidence-based individualized online evaluated it in prospective observational pilot study. The primary outcome was decisional conflict. Secondary...

10.1177/1060028019828420 article EN Annals of Pharmacotherapy 2019-02-06

Background Patients with atrial fibrillation are frequently nonadherent to oral anticoagulants (OACs) prescribed for stroke and systemic embolism (SSE) prevention. We quantified the relationship between OAC adherence clinical outcomes using methods not previously applied this problem. Methods Results Retrospective observational cohort study of incident cases from population‐based administrative data over 23 years. The exposure interest was proportion days covered during 90 before an event or...

10.1161/jaha.124.035639 article EN cc-by-nc-nd Journal of the American Heart Association 2024-09-09

Our previous study in British Columbia (BC) indicated that pharmacists have a poor perception of their working conditions. The objective this is to assess pharmacists' perceptions conditions 4 other Canadian provinces.This was cross-sectional across Alberta, New Brunswick, Prince Edward Island and Newfoundland Labrador, using survey adapted from the Oregon Board Pharmacy. Data collected previously BC were also included analyses. emailed all pharmacist registrants. Respondents provided with 6...

10.1177/1715163520915230 article EN Canadian Pharmacists Journal / Revue des Pharmaciens du Canada 2020-05-01

ABSTRACTBackground: In many jurisdictions, the pharmacist’s role continues to evolve from drug distribution–based service delivery expanded scopes of practice, including independent prescribing medications. Objectives: To assess health authority–based pharmacists’ attitudes, be-liefs, and perceptions about prescribing, determine how may affect their behaviour, identify perceived barriers enablers incorporating it into practice.Methods: An anonymous, cross-sectional online survey 677...

10.4212/cjhp.v72i3.2898 article FR The Canadian Journal of Hospital Pharmacy 2019-06-25

Satisfaction with treatment has been identified as an important contributing factor to adherence oral anticoagulant (OAC) therapy in patients atrial fibrillation (AF). We aimed evaluate the satisfaction level of AF regarding OAC use over time, using validated patient-reported outcome instruments, and identify associated patient characteristics.Participants were recruited from specialized clinics Canada. Eligible who prescribed OACs followed for up 2 years. Participants interviewed via...

10.1016/j.cjco.2021.06.015 article FR cc-by-nc-nd CJC Open 2021-06-29

Abstract Our objectives were to measure long-term adherence oral anticoagulants (OACs) in patients with atrial fibrillation (AF) and identify patient factors associated adherence. Using linked, population-based administrative data from British Columbia, Canada, an incident cohort of adults prescribed OACs for AF was identified. We calculated the proportion days covered (PDC) as a time-dependent covariate each 90-day window OAC initiation until end follow-up. Associations between attributes...

10.1007/s11239-023-02921-8 article EN cc-by Journal of Thrombosis and Thrombolysis 2023-12-16
Coming Soon ...